GANX
Gain Therapeutics, Inc.
$1.81
+0.00 (+0.00%)
At close · Jul 7
Market Cap
$77.20M
Shares
42,654,038
Income-statement, balance-sheet and cash-flow figures extracted from the company's SEC filings — 10-K annual and 10-Q quarterly reports — and standardised for comparison across periods.
Revenue
$55.18K
-60.6%
FY2023
Net Income
-$20.16M
+1.2%
FY2025
Operating Margin
-40328.26%
-27640.2pp
FY2023
Diluted EPS
-$0.61
+31.5%
FY2025
Operating Cash Flow
-$18.47M
+2.2%
FY2025
Chart any reported metric, KPI or segment over time — the full statement history lives here
Search above to add metrics — fundamentals, product and segment revenue, company KPIs, valuation.
| Line Item | TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|---|---|
| — | — | — | $55.18K | $140.11K | $164.99K | $28.88K | |
| $411.51K | — | — | $494.23K | $375.36K | $12.5K | $3637 | |
| $10.72M | $10.21M | $10.79M | $11.52M | $8.38M | $7.16M | $2.26M | |
| $8.98M | $8.5M | $9.56M | $10.79M | $9.54M | $6.83M | $1.25M | |
| — | $94.05K | $84.07K | $83.58K | $64.17K | $15.48K | $9592 | |
| $19.69M | $18.71M | $20.35M | $22.31M | $17.92M | $13.99M | $3.51M | |
| -$19.69M | -$18.71M | -$20.35M | -$22.25M | -$17.78M | -$13.83M | -$3.48M | |
| — | — | — | -40328.26% | -12688.1% | -8379.8% | -12047.54% | |
| — | -$18.62M | -$20.27M | -$22.17M | -$17.71M | -$13.81M | -$3.47M | |
| -$20.3M | -$19.3M | -$19.87M | -$22.19M | -$17.5M | -$13.89M | -$3.57M | |
| $943.68K | $861.12K | $536.82K | $79.28K | $92.98K | $4008 | $5386 | |
| -$21.24M | -$20.16M | -$20.41M | -$22.27M | -$17.59M | -$13.89M | -$3.58M | |
| — | — | — | -40354.33% | -12555.13% | -8418.86% | -12387.67% | |
| -$20.12M | -$19.14M | -$20.91M | -$22.06M | -$17.46M | -$13.83M | -$3.65M | |
| USD/shares | — | -$0.61 | -$0.89 | -$1.71 | -$1.48 | -$1.37 | -$1.33 |
| USD/shares | — | -$0.61 | -$0.89 | -$1.71 | -$1.48 | -$1.37 | -$1.33 |
| shares | — | 32.97M | 22.88M | 13.01M | 11.88M | 10.17M | 2.68M |
| shares | — | 32.97M | 22.88M | 13.01M | 11.88M | 10.17M | 2.68M |
Italic rows are computed from reported lines — open a row's info icon for its formula. Values reflect the latest filing (restatements included); per-share figures on today's split basis. Click a value for its source filing.
TTM: trailing twelve months through the latest reported quarter — flows sum the last four quarters, balances take the latest. 3Y/5Y/10Y columns are trailing CAGR from the newest fiscal year; blank where an endpoint is missing or negative.